| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,652 |
3,795 |
$109K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,604 |
1,359 |
$68K |
| 20610 |
|
1,589 |
1,195 |
$47K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
498 |
412 |
$31K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
590 |
506 |
$25K |
| 73564 |
|
172 |
122 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
478 |
319 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
562 |
389 |
$88.60 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
624 |
441 |
$60.40 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
299 |
225 |
$0.18 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
37 |
28 |
$0.06 |
| 99024 |
|
1,315 |
1,185 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
127 |
106 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
89 |
67 |
$0.00 |